Anthony Mato, MD, MSCE | Authors


Limited Following of Best Practices for CLL Observed in the Real-World Setting

February 20, 2021

Anthony Mato, MD, MSCE, discusses an observational registry study of real-world prognostic biomarker testing, treatment patterns and treatment dosing in a pool of 1461 patients with either chronic lymphocytic leukemia.